Considering that VPHM was very prudent with their acquisition of Vancocin, I am hoping that they are again being prudent with this cash hoard. I believe they stated in the past that they would only stick to drugs w/in their core competency. I think the example you give are outside that realm.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.